World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
71
Citations
20305
World Ranking
1824
National Ranking
779

Medicine

D-Index
74
Citations
21125
World Ranking
19379
National Ranking
9648

Overview

David W. Haas is affiliated with Vanderbilt University Medical Center in the United States. Their research primarily spans the field of Medicine, with a focused exploration of Infectious Diseases, Virology, Emergency Medicine, Epidemiology, and Immunology as notable subfields.

Their scholarly work concentrates strongly on HIV/AIDS-related topics, including drug development and treatment, research and interventions, and addressing health complications associated with HIV. Additionally, Haas's research includes areas such as Tuberculosis research and epidemiology, pharmacological effects and toxicity studies, and Pneumocystis jirovecii pneumonia detection and treatment.

Frequent coauthors in their publications include Richard D. Moore, Timothy R. Sterling, Keri N. Althoff, Michael A. Horberg, and Gary Maartens.

David W. Haas has contributed multiple articles to various publication venues, with some of the most frequent being:

  • Pharmacogenetics and Genomics
  • The Journal of Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries
  • Clinical Infectious Diseases

Recent papers authored or coauthored by Haas include:

  • "A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response" (2021, Nature Genetics)
  • "HLA tapasin independence: broader peptide repertoire and HIV control" (2020, Proceedings of the National Academy of Sciences)
  • "Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV" (2024, JAMA Cardiology)
  • "Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens" (2020, Clinical Infectious Diseases)
  • "Endogenous Retroviral Envelope Syncytin Induces HIV-1 Spreading and Establishes HIV Reservoirs in Placenta" (2020, Cell Reports)

Best Publications

  • Defining the role of common variation in the genomic and biological architecture of adult human height

    Andrew R. Wood;Tonu Esko;Jian Yang;Sailaja Vedantam

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Cryptococcosis in Human Immunodeficiency Virus-Negative Patients in the Era of Effective Azole Therapy

    Peter G. Pappas;John R. Perfect;Gretchen A. Cloud;Robert A. Larsen

  • Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

    David W Haas;Heather J Ribaudo;Richard B Kim;Camlin Tierney

  • HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells.

    Kyra Oswald-Richter;Stacy M Grill;Nikki Shariat;Mindy Leelawong

  • Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment.

    Richard H. Haubrich;Sharon A. Riddler;A. Gregory DiRienzo;Lauren Komarow

  • Extremely low-coverage sequencing and imputation increases power for genome-wide association studies

    Bogdan Pasaniuc;Bogdan Pasaniuc;Nadin Rohland;Nadin Rohland;Paul J. McLaren;Paul J. McLaren;Kiran Garimella

  • Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1: A Randomized, Controlled Equivalence Trial

    Jeffrey L. Lennox;Raphael J. Landovitz;Heather J. Ribaudo;Ighovwerha Ofotokun

  • Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor-Based Regimens.

    Jamison Norwood;Megan Turner;Carmen Bofill;Peter Rebeiro

  • Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study

    David W. Haas;Laura M. Smeaton;Robert W. Shafer;Gregory K. Robbins

  • Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.

    J Fagon;H Patrick;D W Haas;A Torres

  • The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effects and elution kinetics for use in joint arthroplasty.

    John Klekamp;John M. Dawson;David W. Haas;David DeBoer

  • CD1d-restricted Human Natural Killer T Cells Are Highly Susceptible to Human Immunodeficiency Virus 1 Infection

    Alison Motsinger;David W. Haas;Aleksandar K. Stanic;Luc Van Kaer

  • Pharmacogenetics of Plasma Efavirenz Exposure after Treatment Discontinuation: An Adult AIDS Clinical Trials Group Study

    Heather J. Ribaudo;David W. Haas;Camlin Tierney;Richard B. Kim

  • Cohort Profile: The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)

    Stephen J Gange;Mari M Kitahata;Michael S Saag;David R Bangsberg

  • The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adults.

    Mustafa A Noor;Rex A Parker;Edward O'Mara;Dennis M Grasela

  • Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA‐B Genotype and Abacavir Dosing

    Unknown

  • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing

    Roseann S. Gammal;Michael H. Court;Cyrine E. Haidar;Otito Frances Iwuchukwu

  • Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease

    J. W. Baddley;J. R. Perfect;R. A. Oster;R. A. Larsen

  • Bacterial osteomyelitis in adults: evolving considerations in diagnosis and treatment.

    David W. Haas;Mark P. McAndrew

  • HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins

    Zabrina L. Brumme;Zabrina L. Brumme;Mina John;Jonathan M. Carlson;Chanson J. Brumme

  • Treatment of Gram-positive Nosocomial Pneumonia Prospective Randomized Comparison of Quinupristin/Dalfopristin versus Vancomycin

    J. Y. Fagon;H. Patrick;D. W. Haas;A. Torres

Frequent Co-Authors

Marylyn D. Ritchie
Marylyn D. Ritchie University of Pennsylvania
Jacques Fellay
Jacques Fellay École Polytechnique Fédérale de Lausanne
Bruce D. Walker
Bruce D. Walker Harvard University
Edward P. Acosta
Edward P. Acosta University of Alabama at Birmingham
Steven G. Deeks
Steven G. Deeks University of California, San Francisco
Roy M. Gulick
Roy M. Gulick Cornell University
Timothy R. Sterling
Timothy R. Sterling Vanderbilt University Medical Center
David B. Clifford
David B. Clifford Washington University in St. Louis
Eric S. Daar
Eric S. Daar Lundquist Institute
Paul I. W. de Bakker
Paul I. W. de Bakker Vertex Pharmaceuticals (United Kingdom)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a variety of allied health and science careers. For professionals interested in blending healthcare with technology and data management, exploring cahiim accredited health information management programs online can provide essential skills for managing patient data and health records.

Those looking for quicker credentialing options might consider earning an accredited fast medical billing and coding certificate online. This path is ideal for entering the healthcare administration field swiftly while building expertise in medical coding and billing processes.

For graduates focused on clinical or research roles, various online medical programs offer flexible routes to advance their medical knowledge without pausing their careers. These programs range from physician assistant studies to specialized medical certifications.

Public health is another vital career avenue connected to microbiology. Prospective students can explore accredited online mph programs easy to get into that prepare professionals to tackle community health challenges and epidemiology, complementing a microbiology background.

Best Scientists Citing David W. Haas

Trending Scientists